Denosumab Treatment for Fibrous Dysplasia

Fibrous dysplasia (FD) is a skeletal disease caused by somatic activating mutations of the cAMP-regulating protein, G(s)α. These mutations lead to replacement of normal bone by proliferative osteogenic precursors, resulting in deformity, fracture, and pain. Medical treatment has been ineffective in...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Boyce, AM, Chong, WH, Yao, J, Gafni, RI, Kelly, MH, Chamberlain, CE, Bassim, C, Cherman, N, Ellsworth, M, Kasa-Vubu, JZ, Farley, FA, Molinolo, AA, Bhattacharyya, N, Collins, MT
Formato: Artigo
Idioma:Inglês
Publicado: 2012
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3377825/
https://ncbi.nlm.nih.gov/pubmed/22431375
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbmr.1603
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares